ESC 365 - Risk of stroke overall and by stroke severity among newly diagnosed non-valvular atrial fibrillation patients initiating treatment with rivaroxaban versus warfarin

ESC Premium Access

Risk of stroke overall and by stroke severity among newly diagnosed non-valvular atrial fibrillation patients initiating treatment with rivaroxaban versus warfarin

Session: Poster Session 4 - Atrial fibrillation - Stroke prevention

Topic: Oral Anticoagulation

Speaker: Doctor J. Lin (Titusville, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Jennifer Hsiang-Ling Lin

Titusville (United States of America)

0 follower

27 more presentations in this session

The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis.

Speaker: Professor P. Penson (Liverpool, GB)

Net clinical benefit of NOACs vs. VKAs in elderly patients with atrial fibrillation: a pooled analysis from the real-world PREFER in AF and PREFER in AF PROLONGATION registries

Speaker: Doctor I. Cavallari (Rome, IT)

A meta-analysis of efficacy and safety of Watchman device for left atrial appendage closure in non-valvular atrial fibrillation

Speaker: Doctor A. Jhand (Omaha, US)

A metaanlysis for safety and efficacy of amplatzer cardiac plug and amulet device for left atrial appendage closure in patiets with non valvular atrial fibrillation

Speaker: Doctor A. Thandra (Omaha, US)

Use of oral anticoagulation is less among hospitalized patients with paroxysmal compared to persistent or permanent atrial fibrillation

Speaker: Doctor S. Pokorney (Durham, US)

Access the full session

Poster Session 4 - Atrial fibrillation - Stroke prevention

Speakers: Doctor J. Lin, Professor P. Penson, Doctor I. Cavallari, Doctor A. Jhand, Doctor A. Thandra...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources